Gerresheimer AG
XETRA:GXI
Gerresheimer AG
XETRA:GXI
Price:
101.2 EUR
0.8%
Updated:
Apr 30, 2024
Gerresheimer AG
Cash from Operating Activities
|
Gerresheimer AG
Cash from Operating Activities Peer Comparison
Comparables:
E
EVT
S
1SXP
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gerresheimer AG
XETRA:GXI
|
Cash from Operating Activities
€370.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
10%
|
|
E
|
Evotec SE
XETRA:EVT
|
Cash from Operating Activities
-€18.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Cash from Operating Activities
€181.7m
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gerresheimer AG's Cash from Operating Activities?
Cash from Operating Activities
370.7m
EUR
370.7m
EUR
Based on the financial report for Feb 29, 2024, Gerresheimer AG's Cash from Operating Activities amounts to 370.7m EUR.
What is Gerresheimer AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
10%
10%
Over the last year, the Cash from Operating Activities growth was 117%. The average annual Cash from Operating Activities growth rates for Gerresheimer AG have been 15% over the past three years , 18% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
